A Cannabinoid CB(1) Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects

The CB(1) receptor represents a promising target for the treatment of several disorders including pain-related disease states. However, therapeutic applications of Δ(9)-tetrahydrocannabinol and other CB(1) orthosteric receptor agonists remain limited because of psychoactive side effects. Positive al...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuropsychopharmacology
Päätekijät: Ignatowska-Jankowska, Bogna M, Baillie, Gemma L, Kinsey, Steven, Crowe, Molly, Ghosh, Sudeshna, Owens, Robert A, Damaj, Imad M, Poklis, Justin, Wiley, Jenny L, Zanda, Matteo, Zanato, Chiara, Greig, Iain R, Lichtman, Aron H, Ross, Ruth A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864630/
https://ncbi.nlm.nih.gov/pubmed/26052038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2015.148
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia